Market closedADR
Connect Biopharma/$CNTB
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Connect Biopharma
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
Ticker
$CNTB
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
81
Website
CNTB Metrics
BasicAdvanced
$49M
-
-$0.39
-0.34
-
Price and volume
Market cap
$49M
Beta
-0.34
52-week high
$0.94
52-week low
$0.77
Financial strength
Current ratio
12.043
Quick ratio
11.825
Long term debt to equity
0.066
Total debt to equity
0.294
Interest coverage (TTM)
-1,114.70%
Management effectiveness
Return on assets (TTM)
-12.13%
Return on equity (TTM)
-17.92%
Valuation
Price to revenue (TTM)
2.011
Price to book
0.44
Price to tangible book (TTM)
0.44
Price to free cash flow (TTM)
-1.925
Growth
Earnings per share change (TTM)
-77.03%
3-year earnings per share growth (CAGR)
-61.97%
CNTB News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Connect Biopharma stock?
Connect Biopharma (CNTB) has a market cap of $49M as of March 06, 2025.
What is the P/E ratio for Connect Biopharma stock?
The price to earnings (P/E) ratio for Connect Biopharma (CNTB) stock is 0 as of March 06, 2025.
Does Connect Biopharma stock pay dividends?
No, Connect Biopharma (CNTB) stock does not pay dividends to its shareholders as of March 06, 2025.
When is the next Connect Biopharma dividend payment date?
Connect Biopharma (CNTB) stock does not pay dividends to its shareholders.
What is the beta indicator for Connect Biopharma?
Connect Biopharma (CNTB) has a beta rating of -0.34. This means that it has an inverse relation to market volatility.